Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$221,894
+$15,556 QoQ
Shares Held
185
-3.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#4,367
of 4,605 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DB&C Advisors, LLC holds $9,643,722 across 7 Drug Manufacturers - General names. LLY ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
21,009 | $5,286,704 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
12,865 | $1,625,364 | |
| 3 | JNJ |
Johnson & Johnson
|
3,366 | $854,863 | |
| 4 | PFE |
Pfizer Inc
|
31,267 | $752,909 | |
| 5 | AMGN |
Amgen Inc
|
1,394 | $504,795 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,091 | $397,193 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
185 | $221,894 |
All Filings in LLY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $221,894 | 185 | Shares | Sole | 2026-07-31 | |
| 2025-12-31 | $206,338 | 192 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||